“`html
Driving access to better paediatric medicines on World Children’s Day
Since 2015, the decline in infant and child mortality has been slowing, yet there is a lack of research into new life-saving tools targeted at children. This is partly due to the complexity of conducting studies including the youngest age groups.
Driving access to better paediatric medicines on World Children’s Day
Children cannot swallow tablets or capsules, often cannot bear the taste of liquid medicines and metabolize drugs differently as they develop and grow. Paediatric medicines need to be palatable, scored, crushable, dispersible, chewable, sprinkled on food or mixed with breast milk. Appropriate medicines to save and improve the lives of infants and children often do not exist, are unavailable or are not quality assured, especially in low-resource settings.
Exploring innovative approaches for faster access to paediatric medicines for antimicrobial resistance
Our final webinar of 2023 in the GAP-f #BetterMeds4Kids webinar series focuses on exploring innovative approaches for faster access to paediatric medicines for antimicrobial resistance (AMR). The webinar will be hosted on 20 November 2023 at 1400 CET. Click here for more information.
Cefiderocol product brief
Despite huge progress, preventable and treatable infectious diseases remain the leading cause of death among under 5s. Bacterial infections, especially pneumonia, neonatal sepsis and gastrointestinal infections, are the main cause of infectious mortality in this age group worldwide. This problem is further exacerbated by the global rise of antimicrobial resistance.
“`